Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Shionogi & Co. Ltd.
DescriptionProstaglandin D2 (PGD2) receptor subtype DP1 (PTGDR1; DP1) antagonist
Molecular Target Prostaglandin D2 (PGD2) receptor subtype DP1 (PTGDR1) (DP1)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase III
Standard IndicationAllergy
Indication DetailsTreat allergic disease; Treat allergic rhinitis
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today